Public Profile

Adcock Ingram Holdings Limited

Adcock Ingram Holdings Limited, a prominent player in the South African pharmaceutical industry, is headquartered in Johannesburg, South Africa (ZA). Founded in 1890, the company has established itself as a leader in the manufacture and distribution of a diverse range of healthcare products, including prescription medications, over-the-counter drugs, and consumer health products. With a strong presence across Southern Africa, Adcock Ingram is renowned for its commitment to quality and innovation, offering unique formulations that cater to various health needs. The company has achieved significant milestones, including strategic partnerships and expansions that enhance its market position. Adcock Ingram's dedication to improving health outcomes has solidified its reputation as a trusted name in the pharmaceutical sector, making it a key contributor to the region's healthcare landscape.

DitchCarbon Score

How does Adcock Ingram Holdings Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Adcock Ingram Holdings Limited's score of 32 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

59%

Let us know if this data was useful to you

Adcock Ingram Holdings Limited's reported carbon emissions

In 2024, Adcock Ingram Holdings Limited reported total carbon emissions of approximately 131,471,000 kg CO2e. This figure includes Scope 1 emissions of about 17,227,040 kg CO2e, primarily from stationary combustion, and Scope 2 emissions of approximately 52,559,640 kg CO2e, mainly from purchased electricity. Additionally, their Scope 3 emissions totalled around 63,528,750 kg CO2e, with significant contributions from purchased goods and services, upstream transportation, and employee commuting. In 2023, the company recorded total emissions of about 134,028,000 kg CO2e, with Scope 1 emissions at approximately 21,221,000 kg CO2e. However, detailed Scope 2 data was not disclosed for that year. The absence of specific reduction targets or climate pledges indicates that while Adcock Ingram is actively monitoring its emissions, it has not yet committed to formal reduction initiatives or science-based targets. Overall, Adcock Ingram's emissions data reflects a comprehensive approach to carbon accounting, covering all three scopes of emissions. The company continues to engage in climate-related reporting, although further commitments to reduction targets would enhance its sustainability profile.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
21,221,000
00,000,000
Scope 2
-
00,000,000
Scope 3
3,161,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adcock Ingram Holdings Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Adcock Ingram Holdings Limited is in ZA, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adcock Ingram Holdings Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Endo Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Akorn

US
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Lannett Company, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Mallinckrodt plc

IE
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers